Liraglutide's safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
about
Drugs for the treatment of pediatric type 2 diabetes mellitus and related co-morbidities.Comparable liraglutide pharmacokinetics in pediatric and adult populations with type 2 diabetes: a population pharmacokinetic analysis.Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and PharmacodynamicsPharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus.Liraglutide: a review of its use in adult patients with type 2 diabetes mellitus.Liraglutide for Type 2 diabetes and obesity: a 2015 update.Treatment of Pediatric Type 2 Diabetes.Type 1 Diabetes in the Young: Organization of Two National Centers in Israel and Slovenia.Clinical Pharmacokinetics and Pharmacodynamics of Antihyperglycemic Medications in Children and Adolescents with Type 2 Diabetes Mellitus.Lipopeptides as therapeutics: applications and in vivo quantitative analysis.Targeting postprandial glycaemia in children with diabetes: Opportunities and challenges.Optimization of tolerability and efficacy of the novel dual amylin and calcitonin receptor agonist KBP-089 through dose escalation and combination with a GLP-1 analog.Type 1 Diabetes in the Young: Organization of Two National Centers in Israel and Slovenia.
P2860
Q30241716-9D43AD01-8F92-49C5-80B0-C57D0A43A037Q35666210-BAD6E7F1-24BB-4993-B38F-7AC6E20ABF05Q36924102-4EBD8B90-D506-4A4A-908E-FDE05291523FQ37348414-E505ED39-A8F6-46A2-A549-8934C42E8F90Q38264842-D7B6B91A-69BD-4501-9212-763BFE29DD58Q38536672-562D8533-BC86-4A72-8858-5DE38D850637Q38866470-BE1F87AA-689A-4867-8BC0-6E10D9FA7E9EQ38959162-DE05A9F3-A2A2-44D2-997E-70C78203B91DQ39004656-A456F289-33AC-4BBD-BFC9-883550109A19Q39037677-B1CEB240-77A6-4777-9C7D-303E9111FE15Q48123950-2B6ABE9B-8A9B-437D-B270-D62CB275FFAFQ48130202-F554DFD4-BA79-46D8-9252-340429D9E45DQ55009441-9B49F272-73C0-483D-B23C-2650186A977A
P2860
Liraglutide's safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Liraglutide's safety, tolerabi ...... ind, placebo-controlled trial.
@ast
Liraglutide's safety, tolerabi ...... ind, placebo-controlled trial.
@en
Liraglutide's safety, tolerabi ...... ind, placebo-controlled trial.
@nl
type
label
Liraglutide's safety, tolerabi ...... ind, placebo-controlled trial.
@ast
Liraglutide's safety, tolerabi ...... ind, placebo-controlled trial.
@en
Liraglutide's safety, tolerabi ...... ind, placebo-controlled trial.
@nl
prefLabel
Liraglutide's safety, tolerabi ...... ind, placebo-controlled trial.
@ast
Liraglutide's safety, tolerabi ...... ind, placebo-controlled trial.
@en
Liraglutide's safety, tolerabi ...... ind, placebo-controlled trial.
@nl
P2093
P2860
P356
P1476
Liraglutide's safety, tolerabi ...... ind, placebo-controlled trial.
@en
P2093
D J Chatterjee
David J Klein
Lisbeth V Jacobsen
NN2211-1800 Study Group
Paula M Hale
Silva Arslanian
P2860
P304
P356
10.1089/DIA.2013.0366
P577
2014-07-18T00:00:00Z